K Number
K981969
Date Cleared
1998-08-20

(77 days)

Product Code
Regulation Number
882.5050
Panel
NE
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The BRAEBON MEDICAL CORPORATION Ultima Body Position Sensor™ is intended for use during sleep disorder studies as an indicator of body position. The sensor uses a threevolt lithium battery and plugs directly into either a DC amplifier or multiplexer.

Device Description

The BRAEBON MEDICAL CORPORATION Ultima Body Position Sensor™ is intended for use during sleep disorder studies as an indicator of body position. The sensor uses a threevolt lithium battery and plugs directly into either a DC amplifier or multiplexer.

AI/ML Overview

This document is a 510(k) clearance letter from the FDA for the Ultima Body Position Sensor. It confirms substantial equivalence to predicate devices but does not contain information about acceptance criteria, study design, or performance data. Therefore, I cannot generate the requested table or answer most of the questions.

The document states:

  • Device Name: Ultima Body Position Sensor
  • Indications For Use: Intended for use during sleep disorder studies as an indicator of body position in children and adult patients.
  • Predicate Devices: Sleep Position Indicator, Model BPI1, K940013; Mini-Tracker, K923033.

Since the provided document is an FDA clearance letter and not a study report, it does not contain the detailed information necessary to complete the requested table and answer the study-related questions.

§ 882.5050 Biofeedback device.

(a)
Identification. A biofeedback device is an instrument that provides a visual or auditory signal corresponding to the status of one or more of a patient's physiological parameters (e.g., brain alpha wave activity, muscle activity, skin temperature, etc.) so that the patient can control voluntarily these physiological parameters.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter when it is a prescription battery powered device that is indicated for relaxation training and muscle reeducation and prescription use, subject to § 882.9.